Publications by authors named "Yu-Jen Jan"

Background: Obesity and hypercholesterolemia have been associated with better responses to ICIs in NSCLC, while type 2 diabetes (T2D) has been associated with a worse response. However, the association between glucose levels and outcomes remains unknown. This study investigated the impact of mean baseline glucose levels, T2D, dyslipidemia, and obesity on overall survival (OS) in NSCLC patients undergoing ICI therapy.

View Article and Find Full Text PDF

Optimizing outcomes in prostate cancer (PCa) requires precision in characterization of disease status. This effort was directed at developing a PCa extracellular vesicle (EV) Digital Scoring Assay (DSA) for detecting metastasis and monitoring progression of PCa. PCa EV DSA is comprised of an EV purification device (i.

View Article and Find Full Text PDF

A major metastasis suppressing mechanism is the rapid apoptotic death of cancer cells upon detachment from extracellular matrix, a process called anoikis. Focal adhesion kinase (PTK2/FAK) is a key enzyme involved in evasion of anoikis. We show that loss of the Cub-domain containing protein-1 (CDCP1), paradoxically stimulates FAK activation in the detached state of prostate cancer cells.

View Article and Find Full Text PDF

• PRES is potentially a complication of severe SARS-CoV-2 infection. • Consider PRES in COVID-19 patients with altered mentation. • Consider tight blood pressure control in ventilated patients with COVID-19.

View Article and Find Full Text PDF

Purpose Of Review: The purpose of this review is to highlight recent research advances in noninvasive prenatal diagnostic methods.

Recent Findings: Recent studies developing noninvasive prenatal diagnostic (NIPD) methods have been focused on either fetal nucleated red blood cells (fNRBCs) or circulating trophoblasts (cTBs). Enriched cTBs were successfully utilized for whole genome profiling and short tandem repeat (STR) identification to confirm feto-maternal relationship.

View Article and Find Full Text PDF

Well-preserved mRNA in circulating tumor cells (CTCs) offers an ideal material for conducting molecular profiling of tumors, thereby providing a noninvasive diagnostic solution for guiding treatment intervention and monitoring disease progression. However, it is technically challenging to purify CTCs while retaining high-quality mRNA.Here, we demonstrate a covalent chemistry-based nanostructured silicon substrate ("Click Chip") for CTC purification that leverages bioorthogonal ligation-mediated CTC capture and disulfide cleavage-driven CTC release.

View Article and Find Full Text PDF
Article Synopsis
  • - Our study aimed to create a test (NanoVelcro CTC-RNA assay) to analyze RNA from circulating tumor cells (CTCs) in metastatic castration-resistant prostate cancer (mCRPC) patients to predict their sensitivity to androgen receptor signaling inhibitors (ARSIs).
  • - We focused on a specific cancer subtype (PCS1) known for its severity and resistance to ARSIs, using advanced technologies for cell purification and RNA analysis, and rigorously validated our approach with prostate cancer cell lines.
  • - Testing on patient blood samples showed our assay can identify the PCS1 subtype accurately, with higher scores linked to ARSI resistance, confirming its potential to guide treatment decisions for mCRPC patients.
View Article and Find Full Text PDF

Tumor-derived extracellular vesicles (EVs) present in bodily fluids are emerging liquid biopsy markers for non-invasive cancer diagnosis and treatment monitoring. Because the majority of EVs in circulation are not of tumor origin, it is critical to develop new platforms capable of enriching tumor-derived EVs from the blood. Herein, we introduce a biostructure-inspired NanoVilli Chip, capable of highly efficient and reproducible immunoaffinity capture of tumor-derived EVs from blood plasma samples.

View Article and Find Full Text PDF

Professor Donald Coffey and his laboratory pioneered studies showing the relationships between nuclear shape and cellular function. In doing so, he and his students established the field of nuclear morphometry in prostate cancer. By using perioperative tissues via biopsies and surgical sampling, Dr.

View Article and Find Full Text PDF
Article Synopsis
  • * Detecting CTCs is difficult due to their low numbers in the blood, but UCLA's research team developed "NanoVelcro" technology to efficiently capture these cells using specialized substrates.
  • * Four generations of NanoVelcro Chips have been created over the years, improving the isolation, purification, and viability of CTCs for further analysis of cancer biomarkers.
View Article and Find Full Text PDF

A glycan-stimulated and poly(3,4-ethylene-dioxythiophene)s (PEDOT)-based nanomaterial platform is fabricated to purify circulating tumor cells (CTCs) from blood samples of prostate cancer (PCa) patients. This new platform, phenylboronic acid (PBA)-grafted PEDOT NanoVelcro, combines the 3D PEDOT nanosubstrate, which greatly enhances CTC capturing efficiency, with a poly(EDOT-PBA-co-EDOT-EG3) interfacial layer, which not only provides high specificity for CTC capture upon antibody conjugation but also enables competitive binding of sorbitol to gently release the captured cells. CTCs purified by this PEDOT NanoVelcro chip provide well-preserved RNA transcripts for the analysis of the expression level of several PCa-specific RNA biomarkers, which may provide clinical insights into the disease.

View Article and Find Full Text PDF

Circulating fetal nucleated cells (CFNCs) in maternal blood offer an ideal source of fetal genomic DNA for noninvasive prenatal diagnostics (NIPD). We developed a class of nanoVelcro microchips to effectively enrich a subcategory of CFNCs, i.e.

View Article and Find Full Text PDF